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Abstract
We previously demonstrated that hexokinase II (HK2) dissociation from mitochondria during
cardiac ischemia correlates with cytochrome c (cyt-c) loss, oxidative stress and subsequent
reperfusion injury. However, whether HK2 release is the primary signal mediating this ische-
mia-induced mitochondrial dysfunction was not established. To investigate this, we studied
the effects of dissociating HK2 from isolated heart mitochondria. Mitochondria isolated from
Langendorff-perfused rat hearts before and after 30 min global ischemia ± ischemic precon-
ditioning (IPC) were subject to in vitro dissociation of HK2 by incubation with glucose-6-
phosphate at pH 6.3. Prior HK2 dissociation from pre- or end-ischemic heart mitochondria
had no effect on their cyt-c release, respiration (± ADP) or mitochondrial permeability transi-
tion pore (mPTP) opening. Inner mitochondrial membrane morphology was assessed indi-
rectly by monitoring changes in light scattering (LS) and confirmed by transmission electron
microscopy. Although no major ultrastructure differences were detected between pre- and
end-ischemia mitochondria, the amplitude of changes in LS was reduced in the latter. This
was prevented by IPC but not mimicked in vitro by HK2 dissociation. We also observed
more Drp1, a mitochondrial fission protein, in end-ischemia mitochondria. IPC failed to pre-
vent this increase but did decrease mitochondrial-associated dynamin 2. In vitro HK2 disso-
ciation alone cannot replicate ischemia-induced effects on mitochondrial function implying
that in vivo dissociation of HK2 modulates end-ischemia mitochondrial function indirectly
perhaps involving interaction with mitochondrial fission proteins. The resulting changes in
mitochondrial morphology and cristae structure would destabilize outer / inner membrane
interactions, increase cyt-c release and enhance mPTP sensitivity to [Ca2+].
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Introduction
Reperfusion injury occurs upon restoration of blood flow after a prolonged period of ische-
mia. It has major clinical significance because reperfusion is essential to restore heart function
yet may precipitate further irreversible injury, and thus limit the extent of myocardial salvage.
A key player in ischemia-reperfusion (I/R) injury is the opening of a non-selective, high con-
ductance channel in the inner mitochondrial membrane (IMM) known as the mitochondrial
permeability transition pore (mPTP) [1] whose exact molecular identity remains uncertain
[2–5]. It has been widely accepted that the major triggers for mPTP opening during reperfu-
sion are elevated [Ca2+]m and reactive oxygen species (ROS) [1]. It has been further proposed
that ROS are generated early in reperfusion by reverse electron flow through Complex I of the
respiratory chain during oxidation of succinate that accumulates in ischemia [6]. However,
our own real-time surface fluorescent measurements of ROS during reperfusion do not sup-
port this hypothesis [7]. Indeed, ischemic preconditioning (IPC), in which hearts are exposed
to several brief periods of ischemia and reperfusion prior the prolonged ischemic episode, is
strongly cardioprotective but is not accompanied by a reduction in succinate accumulation
[7, 8]. Furthermore, Cyclosporine A (CsA), a specific inhibitor of the mPTP that acts by bind-
ing to an established regulatory component of the pore (cyclophilin D), has failed to show
reduction in mortality and adverse effects of I/R in clinical settings [9] despite its cardiopro-
tection in many animal models. These observations raise the question whether simple inhibi-
tion of the mPTP is sufficient to prevent I/R injury and whether targeting events upstream of
mPTP opening might be more effective.
In this respect, we have previously shown that although the mPTP remains closed during
ischemia [10], events occurring during this period sensitize mitochondria to mPTP opening at
reperfusion [11]. Thus, mitochondria isolated from ischemic hearts are much more sensitive
to mPTP opening than those from control hearts. However, IPC or pharmacological precondi-
tioning attenuates this sensitization [11, 12] and thus leads to less mPTP opening on reperfu-
sion and consequently less injury. More recently [7] we showed that IPC did not attenuate the
elevated [Ca2+]m at the end of ischemia or ROS production in the first 90 s of reperfusion yet
mPTP opening after 1 min and subsequent ROS production was attenuated. This confirms
that mitochondria experience an effect during ischemia that determines mPTP opening and
thus the extent of injury on reperfusion. In this regard, ischemia is associated with a decrease
in the amount of hexokinase 2 (HK2) bound to mitochondria which is caused by accumulation
of glucose-6-phosphate (G6P) and a drop in cytosolic pH that occurs as a result of enhanced
glycolysis during this phase [13]. IPC attenuates these metabolic changes and prevents the dis-
sociation of mitochondrial-bound HK2 (mt-HK2), suggesting this may be an important com-
ponent of the IPC mechanism. In this context it should be noted that mitochondria-bound
HK2 has also been implicated in the resistance of tumour cell mitochondria to mPTP opening
[14–17]. Furthermore, extensive earlier studies from our laboratory [13, 18, 19] and those of
others [20–23] have demonstrated a strong correlation between dissociation of mt-HK2 dur-
ing ischemia and cytochrome c release and infarct size at reperfusion. In this regard, cyto-
chrome c loss decreases superoxide scavenging and promotes ROS production [19] which are
known inducers of the mPTP [1]. By contrast, IPC does not reduce the accumulation of succi-
nate, a proposed source of ROS, during ischemia or the rate of its subsequent decline on reper-
fusion [7, 8] but does prevent HK2 loss from mitochondria during ischemia [13]. Yet, despite
the numerous reports about hexokinase(s) on cell survival, either in the context of cardiovas-
cular injury and/or cancer, none of these papers provide definite evidence of whether or how
HK2 can modulate mPTP opening directly. Rather they have primarily investigated upstream
events leading to mt-HK2 release, such as the potential roles of Akt and GSK3beta, reporting
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mt-HK2 dissociation as the last event in a cascade that leads to mPTP opening. They do not
provide evidence that HK2 directly regulates mPTP opening.
Previous data from our laboratory have offered some insights into the mechanism by which
mt-HK2 might interact with the mPTP. We observed that rates of phosphocreatine (PCr)
regeneration following prolonged ischemia are depressed [13], suggesting a disruption of the
PCr-dependent energy shuttling system that involves interactions between the outer and inner
mitochondrial membranes (OMM and IMM). Another hetero-protein complex found at
points of juxtaposition between OMM and IMM comprises the adenine nucleotide translocase
(ANT), the voltage-dependent anion channel (VDAC) and, importantly for the present study,
HK [24]. Interestingly, we [25] and others [26] have reported that modulation of such contact
sites in isolated mitochondria is associated with cytochrome c release and increased sensitivity
to mPTP opening. These data suggest a plausible role for OMM and IMM interactions in link-
ing extra-mitochondrial events that occur during ischemia to sensitization of mPTP opening
during I/R.
The primary aim of this study was to establish whether the deleterious effects of ischemia
on mitochondria in vitro can be mimicked purely by displacing mt-HK2. Using a brief incuba-
tion with G6P at pH 6.3 during mitochondrial isolation, we have dissociated HK2 from mito-
chondria isolated from pre-ischemic and end-ischemic control and IPC hearts and
subsequently measured OMM permeabilization (OMMP), the sensitivity of the mPTP and
changes in OMM and IMM morphology. Our rationale is that, if prevention of HK2 dissocia-
tion from mitochondria is directly responsible for the attenuation of changes to mitochondria
function at the end of ischemia, then its removal from IPC end-ischemic mitochondria should
change these parameters back to those of non-preconditioned end-ischemic mitochondria.
However, our data reveal that HK2 dissociation in vitro does not replicate ischemia-induced
effects on these parameters which leads us to conclude that release of mitochondrial-bound
HK2 in vivo must affect mitochondrial morphology and function indirectly. We present pre-
liminary evidence that this may be achieved by modulating the binding of the mitochondrial
fission proteins Drp1 and mitochondrial-associated dynamin 2 (Dyn2).
Material and methods
Animals
Male Wistar rats, RccHan:WIST (225–275 g), were purchased from Harlan (Oxfordshire, UK),
acclimatized for 5–7 days prior to the initiation of experiments and maintained in the local
animal house facility (Biomedical Sciences Building, University of Bristol, Bristol, UK). Ani-
mals were group-housed in grilled top type IV cages with corncob grit bedding and environ-
mental enrichment (irradiated tissue paper and cardboard for nest building and shelter) as
means of improving animal welfare. Cages were maintained under controlled environmental
requirements (22 ˚C, 45–65% humidity, 15–20 air changes/hour, 12 h artificial light/dark
cycle, noise level< 55 dB); and, free access to rodent food (EURodent Diet 22%, 5LF5, Labdiet,
St. Louis, MO, US) and water ad libitum. Animals were euthanized by concussion followed by
cervical dislocation, and hearts were immediately extracted from the body and quickly
immersed in ice-cold Krebs–Henseleit buffer.
Animal handling was performed in accordance with the European Convention for the Pro-
tection of Vertebrate Animals used for Experimental and Other Scientific Purposes (CETS
no.123), the UK Animals (Scientific Procedures) Act 1986 amendment regulations 2012 and
was approved by the appropriate University of Bristol ethics committee (UB/09/012). G.C.P. is
credited by the European Federation for Laboratory Animal Research (FELASA) category C
for animal experimentation (accreditation no. 020/08).
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Heart perfusion
Langendorff retrograde heart perfusion was performed as previously described [18] using con-
stant flow (12 mL/min) with Krebs–Henseleit buffer (NaCl 118 mM, NaHCO3 25 mM, KCl
4.8 mM, KH2PO4 1.2 mM, MgSO4 1.2 mM, glucose 11 mM and CaCl2 1.2 mM) gassed with
95% O2 / 5% CO2 at 37 ˚C. After cannulation, hearts were perfused for 35 min followed by 30
min global normothermic ischemia (index ischemia), induced by halting perfusion and
immersing the heart in perfusion buffer at 37 ˚C. Ischemic pre-conditioning (IPC) was
induced after 20 min perfusion by three cycles of 2 min ischemia plus 3 min reperfusion before
entering index ischemia as described above. Hemodynamic monitoring was achieved by
inserting a latex balloon connected to a pressure transducer into the left ventricle. Data acqui-
sition and analysis were performed using PowerLab/LabChart (AdInstruments, Oxford, UK).
A summary of the hemodynamic data is presented in the supplemental S1, S2 and S3 Tables.
For hearts used to assess the content of mitochondrial dynamic proteins (ie., Drp1, Mff and
Dyn2) the standard perfusion protocol was changed as following: control perfusion (pre-ische-
mia), 45 min perfusion; end-ischemia, 15 min stabilisation followed by 30 min global normo-
thermic ischemia; IPC, 15 min stabilisation followed by 3 cycles of 2 min bursts of ischemia
separated by 3 min perfusion, then 30 min global normothermic ischemia.
Assessment of infarct size
For assessment of infarct size hearts were reperfused for 120 min after ischemia before perfus-
ing for 2 min at 10 mL/min with a 1% (w/v) TTC solution. Hearts were then detached from
the cannula and incubated for an additional 5 min at 37 ˚C before being sliced perpendicular
to the longitudinal axis into 6 slices. The slices were then fixed in 4% (w/v) formalin solution
overnight at 4˚C. Both sides of each slice were imaged on a standard office scanner and acqui-
sition settings were maintained for all analysed hearts. The surfaces of the necrotic and area at
risk of each side for each slice were determined by planimetry using a color threshold in Ima-
geJ (NIH, Bethesda, MD, USA). Because global ischemia was used, infarct size was expressed
as a percentage of the total cross-sectional area of the heart. A summary of the data obtained is
shown in the supplemental S3 Table.
Mitochondria isolation
Hearts were removed from the cannula either before entering ischemia (pre-ischemia) or at
the end of ischemia, and immediately immersed in ice-cold isolation buffer (sucrose 300 mM,
EGTA 2 mM, and Tris-HCl 10 mM, pH 7.3 at 4 ˚C). Mitochondria were isolated through dif-
ferential centrifugation as described previously [18], with slight modifications. All steps were
performed at 4 ˚C. Briefly, hearts were finely chopped with a razor blade on a glass petri dish
and incubated at 4 ˚C for 4.5 min with stirring in a small beaker with 6 mL of isolation buffer
supplemented with 1.12 U/mL of protease (EC 3.4.21.62, Subtilisin A) from Bacillus lichenifor-
mis (aqueous propylene glycol solution from Sigma-Aldrich, Dorset, UK). The suspension was
then filtered through a nylon mesh (100 μm) and washed with 7 volumes of isolation buffer
before transfer into a glass Potter homogenizer. Homogenization was carried out in 25 mL of
isolation buffer supplemented with 0.5% defatted BSA for about 2 min using a motorized Tef-
lon pestle. The homogenate was centrifuged at 7,500 g for 7 min, and the resulting pellet was
re-suspended in 25 mL of isolation buffer with BSA and subjected to additional homogeniza-
tion as described earlier. The suspension was then centrifuged at 700 g for 10 min and the
resultant supernatant saved while the pellet was re-suspended in 25 mL of isolation buffer,
homogenized as previously described in isolation buffer and centrifuged at 700 g for 10 min.
This second supernatant was mixed with the first and centrifuged at 7,000 g for 10 min to yield
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a crude mitochondrial pellet. Half of each pellet was re-suspended in 10 mL of normal isolation
buffer and half in isolation buffer containing 10 mM G6P at pH 6.3; both were then centrifuged
at 7,000 g for 10 min. The resulting pellets were re-suspended in isolation buffer containing
25% (w/v) Percoll (pH 7.2 at 4 ˚C) and centrifuged at 17,000 g for 10 min. The mitochondrial
pellets were re-suspended in isolation buffer and centrifuged again at 7,000 g for 10 min. The
final purified mitochondrial pellets were re-suspended in a small volume of isolation buffer,
and the protein concentration determined by the Biuret method using BSA as a standard.
Mitochondria were kept on ice at a final concentration of 20–25 mg/mL and used within 4
hours. The protocol for mitochondrial preparation and treatment is summarized in S1 Fig.
For hearts used to assess the content of mitochondrial dynamic proteins (ie., Drp1, Mff and
Dyn2) a modification of the polytron method [18] was used instead. Briefly, left ventricle was
immersed in 6 mL ice-cold isolation buffer (300 mM sucrose, 3 mM EGTA, 10 mM Tris-HCl,
pH 7.1) supplemented with 20 mM NEM, 1x complete protease inhibitors (Roche) and 1x
phosphatase inhibitors. Tissue was rapidly chopped into fine pieces before homogenization
using a Polytron tissue disruptor (Kinematica) at 10,000 rpm with 2 bursts of 5 seconds fol-
lowed by 1 burst of 10 seconds. Tissue homogenate was diluted to 20 mL total volume with iso-
lation buffer supplemented with 1x complete protease inhibitors and further homogenized by
hand for 2 min using a glass Potter homogenizer and Teflon pestle. A small volume of homog-
enate was stored at -80 ˚C as whole homogenate. The homogenate was centrifuged at 7,500 g
for 7 min. The pellet was rinsed twice with 5 mL isolation buffer, resuspended in 20 mL isola-
tion buffer and further hand-homogenized for 2 min. The homogenate was then centrifuged
at 600 g for 10 min and the supernatant was centrifuged at 7,000 g for 10 min to yield a crude
mitochondrial pellet, which was resuspended in isolation buffer and stored at -80 ˚C. All frac-
tions were assayed for protein concentration using a standard BCA assay protocol prior to use
for Western blotting.
Mitochondrial respiration
Oxygen consumption by isolated mitochondria was monitored polarographically with an Oxy-
graph-2k (Oroboros Instruments, Innsbruck, Austria) at 37 ˚C in a 2 mL chamber with stan-
dard respiration medium (KCl 125 mM, MOPS 20 mM, Tris 10 mM, EGTA 10 μM, KH2PO4
2.5 mM, and MgCl2 2.5 mM, adjusted to pH 7.3 at room temperature with KOH). The respira-
tory substrates, 5 mM L-glutamate, 2 mM L-malate and 5 mM succinate, were added to the
reaction chamber and allowed to equilibrate before addition of 0.25 mg/mL of mitochondria
and closing of the chamber. After a stable state 2 respiration was achieved, ADP in excess (1.5
mM) was added, followed by 10 μM of cytochrome c to assess the permeability of the mito-
chondrial outer membrane to cytochrome c (indicated by the extent to which the rate of respi-
ration was enhanced). Experiments were performed in duplicate using both Oxygraph-2k
chambers. Respiration rates were calculated as the average value over a 45 s window in DatLab
5 (Oroboros Instruments) and are expressed in nmol O2 / min /mg protein.
Mitochondrial permeability transition
Opening of the mPTP in isolated mitochondrial fractions was assessed both in energized and
de-energized conditions. In energized conditions, extramitochondrial [Ca2+] was assayed by
monitoring Fura-FF (Life Technologies, Paisley, UK) fluorescence in a multi-wavelength fluo-
rimeter (Cairn Instruments, Kent, UK). Excitation filters, 340/20 nm and 380/20 nm, were
contained in a spinning wheel rotating continuously at 32 Hz. Emission fluorescence was
detected at 90˚ with a photomultiplier using a 520 nm bandpass filter. Mitochondria (0.25 mg/
mL) were incubated at 30 ˚C within a stirred cuvette containing 2 mL assay buffer (KCl 125
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mM, MOPS 20 mM, TRIS 10 mM, EGTA 20 μM, KH2PO4 2 mM and Fura-FF 1 μM, pH 7.2 at
30 ˚C) supplemented with respiratory substrates (5 mM L-glutamate, 2 mM L-malate and 5
mM succinate). Additions of 20 μM free [Ca2+] were made every 2 min through an injection
port (first pulse of 50 μM [Ca2+]total). Calcium-loading capacity was calculated as the sum of
number of Ca2+ pulses until mPTP opening, defined by an incomplete plateau before the next
Ca2+ addition.
Under de-energized conditions, mPTP was determined by following the decrease in light
scattering at 520 nm (A520) using a split-beam spectrophotometer with computerized data
acquisition [27]. Mitochondria (0.25 mg/mL) were incubated at 25 ˚C within a stirred cuvette
containing 2 mL assay buffer (KCl 125 mM, MOPS 20 mM, TRIS 10 mM, nitrilotriacetic acid
(NTA) 2 mM, KH2PO4 2.5 mM, rotenone 1 μM, antimycin A 1 μM and A23187 2 μM, pH 7.2
at 25 ˚C). A23187 was present to ensure complete equilibration of Ca2+ across the mitochon-
drial inner membrane under de-energized conditions [28]. Addition of a single pulse of
83.5 μM [Ca2+]free (1mM [Ca2+]total) was made through an injection port after an 80 s baseline.
Variation in the initial A520 (~0.5) was less than 10%. The initial rate of decrease in A520 was
calculated as the minimum of the first derivative of the A520 time course.
In both cases, values of free [Ca2+] were calculated by a ligand-binding program (METLIG),
as previously described [29]. Whenever indicated, 0.2 μM of cyclosporine A (CsA) was added
in order to desensitize mPTP opening [30].
Measurement of inner mitochondrial morphology
Extensive work from the laboratories of Sirak [31] and Klingenberg [32] demonstrated that
ANT ligands modulate the light scattering (LS) of mitochondrial suspension as the ANT
switches between its ‘c’ and ‘m’ conformations. Previous work from this laboratory has shown
that these LS changes are independent of changes in mitochondrial matrix volume and may
therefore provide an alternative means by which to monitor cristae morphology [33]. Here we
use this approach in mitochondria isolated from the perfused heart either before ischemia of
after 30 min ischemia with or without IPC.
Light scattering measurements. Light scattering (LS) was monitored at 520 nm (A520) in
a split-beam spectrophotometer with computerized data acquisition (1 data point per sec).
Mitochondria (0.375 mg/mL) were suspended in assay buffer (KCl 125 mM, MOPS 20 mM,
TRIS 10 mM, EGTA 0.5 mM, pH 7.2 at 25 ˚C) supplemented with respiratory substrates (5
mM L-glutamate, 2 mM L-malate and 5 mM succinate) and oligomycin (1 μM) at 25 ˚C. Equal
volumes (2 mL) were used in sample and reference cuvettes and additions (463.5 μM [Ca2
+]total equivalent to 1 μM [Ca2+]free, 0.2 mM ADP and 5 μM CAT) were made to the sample
cuvette as required through an injection port followed by stirring for 5 s. Variation in the ini-
tial A520 (~0.5) was less than 10%. The magnitude of the changes in A520 was calculated after
signal stabilization and was expressed relative to the A520 prior to effector addition (or baseline
for the first addition). The rate of change in A520 was calculated as the maximum (negative or
positive) of the first derivative of the absorbance traces. Free [Ca2+] was calculated by a ligand-
binding program (METLIG), as previously described [29].
Transmission electron microscopy. Assessment of mitochondrial ultrastructure was per-
formed by TEM. Mitochondria were incubated as for LS measurements above, but protein
concentration was scaled up to 0.75 mg/mL. When A520 reached a constant signal, the mito-
chondrial suspension was fixed by addition of glutaraldehyde (3% (w/v) final) and incubated
for 20 min at room temperature. Mitochondria were then sedimented by centrifugation at
3,000 g for 1 min and re-suspended in 0.1 M cacodylate for 10 min. The procedure was
repeated twice before post-fixation with 1% (w/v) osmium tetraoxide in cacodylate buffer for
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20 min at room temperature. Samples were washed 3 times with cacodylate buffer followed by
standard embedding in Epon 812. Sections (60nm) were contrasted with Ur-acetate and Pb-
citrate and analyzed on a FEI Technai12 TEM.
Mitochondria were classified and counted accordingly to their inner membrane morphol-
ogy as illustrated in Fig 6: Type I, mitochondria present evenly spaced cristae with regular
width; Type II, mitochondria present irregular cristae width but cristae are still thread-like, tra-
versing from OMM to OMM. Spacing between cristae becomes irregular. Type III, mitochon-
dria show a Type II configuration but at least two vesicular-like cristae are present. This
reflects a combination between Type II and Type IV configurations. Type IV, mitochondria
present rounded, nearly vesicular cristae without cristae traversing. Counting was performed
in duplicate using non-overlapping micrographs and by two independent operators blind to
the treatment whose scoring (agreeing within 10%) was averaged.
For morphometric analysis each mitochondrion was manually segmented and the respec-
tive mask used to measure its area, perimeter, circularity (4π.[area/perimeter^2]) and aspect
ratio (major axis/minor axis). For segmentation of all mitochondrial membranes a band pass
filter was applied to the original EM picture in order to filter large structures down to 40 pixels
and small structures up 10 pixels. Then, an Otsu threshold filtering was applied to the pro-
cessed image and the resulting mask used to analyze particles with an average size bigger than
5000 pixels (S7 Fig). A summary of the data obtained is shown in the supplemental S4 Table.
Image processing was performed in FIJI (ImageJ v1.51d).
Western blot
Isolated mitochondrial fractions were diluted to 2.5 mg/mL in sample buffer (Tris 25 mM,
glycerol 6% (w/v), SDS 5% (w/v), EDTA 1 mM and bromophenol blue 0.005% (w/v)) supple-
mented with 5% (w/v) β-mercaptoethanol and heated at 95 ˚C for 5 min. Proteins were sepa-
rated in 5% (HK2 and HK1) or in 12% (ANT, Drp1, Mff, Dyn2) polyacrylamide casted gels by
SDS-PAGE using 20 μg per lane. Gels were then subjected to Western blotting with the
required primary antibody (HK2 (C64G5) rabbit monoclonal dilution 1:1,000, cat. #2867, Cell
Signalling, Hertfordshire, UK; HK1 mouse monoclonal 5G9 dilution 1:1,000, cat. #
WH0003098M1, Chemicon Millipore, Watford, UK; ANT—raised in-house against the C ter-
minus of rat ANT [34], dilution 1:1,000; Drp1 mouse monoclonal dilution 1:1,000, cat.
#611112, BD Biosciences, Wokingham; Dyn2 mouse monoclonal dilution 1:1,1000, cat. #
SAB4200661, Sigma-Aldrich; Mff mouse monoclonal C11 dilution 1:2,000, cat. #sc-398731,
Santa-Cruz Biotechnology, USA; GAPDH mouse monoclonal 6C5 dilution 1:20,000, cat.
#ab8245, AbCam, Cambridge, UK; VDAC-1/2/3 rabbit polyclonal FL-283 dilution 1:1,1000,
cat. #sc-9878, Santa-Cruz Biotechnology) and blots were developed using the required Ig HRP
(horseradish peroxidase) secondary antibody, with ECL/ECL+ detection (Amersham Biosci-
ences, Buckinghamshire, UK). Appropriate exposures of the film were used to ensure that
band intensities were within the linear range. Quantification of blots was performed using an
Alpha Inotech ChemiImager 4400 (Alpha Innotech Corp., San Leandro, CA, USA) to image
the blot and analysis of band intensity with Quantity One (Bio-Rad Laboratories, Hercules,
CA, USA). For densitometry, a rectangle with the maximum size similar to the band of greatest
length present in the blot was considered as the region of interest and was used through the
entire blot. Total band density, defined as the sum of all pixels intensity corrected for the local
mean background was used. Each blot contained samples of (± low pH + G6P) pre-ischemic,
end-ischemic and IPC end-ischemia mitochondria to allow direct comparisons between
groups using the same film exposure. In order to normalize band intensities, parallel blots
were performed on the same samples using antibodies against the ANT.
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Enzyme activities
Isolated mitochondrial fractions were disrupted using hypotonic shock induced by dilution to
2 mg/mL in phosphate buffer (KH2PO4 33 mM pH 7.2 at room temperature) and incubation
for 15 min on ice followed by one cycle of freeze-thaw.
Total hexokinase activity was evaluated in 1 mL of assay buffer (pH 7.4 at room tempera-
ture) containing Tris-HCl 100 mM, NADP+ 0.4 mM, MgCl2 10 mM, ATP 5 mM, Triton X-
100 0.3% (v/v), G6P dehydrogenase 0.5 U/mL and 60 μg of protein. The reaction was carried
out at 37 ˚C in an Evolution 300 UV-Vis Spectrophotometer (Thermo Fisher Scientific, Wal-
tham, MA, USA) and started after a 2 min baseline by addition of glucose (1 mM final). Hexo-
kinase activity was calculated from the rate of NADPH production over the linear part of the
assay (8 min) using an extinction coefficient of 6.22 mM-1.cm-1 [35]. Values were then normal-
ized to citrate synthase activity and expressed as nmol NADPH/min/citrate synthase unit.
Citrate synthase activity was evaluated in 1 mL of assay buffer (pH 7.4 at room tempera-
ture) containing Tris-HCl 50 mM, Triton X-100 0.3% (v/v), and 5,50-dithiobis-2-nitrobenzoic
acid (DTNB) 150 μM, acetyl-coenzyme A 0.3 mM and 10 μg of protein. The reaction was car-
ried at 37 ˚C and started after a 2 min baseline by addition of oxaloacetic acid (500 μM final).
Citrate synthase activity was expressed in μmol /min/mg protein.
Statistical analysis
All data were assessed for normality using the Kolmogorov-Smirnov test with Dallal-Wilkin-
son- Lillie for correction. Overall, analyzed data were normally distributed. Since group sample
sizes are equal and the parametric statistical tests applied are robust for moderate deviations
from homoscedasticity, parametric tests were always applied [36]. Statistical significance
between groups was determined using matched-pairs (± G6P low pH) two-way ANOVA with
interaction; perfusion protocol and low pH + G6P were the factors in use. Two types of compar-
isons were performed: 1) main perfusion protocol effect against end-ischemia group; 2) low pH
+ G6P effect individually analyzed for each perfusion group. In both cases, p values were
adjusted for multiple comparisons through Holm-Šı́dák pos-hoc test and differences were con-
sidered significant at 5% level.
Frequency distributions of morphometric data from EM were expressed relatively to the
total number of measured objects (mitochondria; S4 Table), with bin range and width defined
automatically by the software (Graph Pad Prism). Afterwards, a Gaussian distribution was fit-
ted to the data and independent fits between groups were compared to a global fit sharing the
same mean by the extra sum-of-squares F test. The resulting p value was adjusted for multiple
comparisons through Holm-Šı́dák pos-hoc test and differences were considered significant at
5% level.
Statistical analyses were performed using Graph Pad Prism version 6.01 (GraphPad Soft-
ware, Inc., San Diego, CA, USA).
Results
Hemodynamic parameters during ischemia and IPC
Under the perfusion conditions used in the present studies, there were no differences in hemo-
dynamic data between ‘pre-ischemia’ and ‘end-ischemia’ groups prior to entering ischemia
(S1 Table). Hearts subjected to 30 min global ischemia showed an onset of ischemic contrac-
ture at 11.9 ± 0.7 min (S2 Table) and developed an infarct area upon 2 h reperfusion of
24.7 ± 2.0% (S3 Table). As expected, IPC treatment lowered aortic pressure and rate pressure
product at the end of the stabilization period (S1 Table) and reduced the time to ischemic
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contracture (7.8 ± 0.2 min) and infarct size (5.2 ± 0.7%) at reperfusion (S2 and S3 Tables,
respectively).
In vitro dissociation of mitochondrial-bound HK2
Previously we demonstrated that mitochondria-bound HK2 requires both an increase in G6P
and a decrease in pH to be released from mitochondria in situ [18]. Thus, to promote HK2 dis-
sociation in vitro, we modified the standard mitochondrial isolation protocol by including an
extra washing step with either the standard isolation buffer (normal) or one supplemented
with 10 mM G6P at pH 6.3 (low pH + G6P). It should be noted that the G6P and low pH are
not present in the final wash and thus are not carried through into subsequent assays of mito-
chondrial function (see S1 Fig). We believe this protocol to be preferable to the use of synthetic
peptides mimicking the HK2 binding peptide since these might be carried through into the
assay and mimic the bound HK2 in its effects on the mPTP. Indeed, isolated cardiac mito-
chondria of mice overexpressing GFP fused to this peptide show successful dissociation of mt-
HK2 but retention of the recombinant protein [37].
The western blot data of Fig 1a demonstrate that, as anticipated, our low pH + G6P protocol
was effective in removing all bound HK2 from mitochondria isolated from control, ischemic and
IPC ischemic hearts. These data also confirm our earlier observation that ischemia induces disso-
ciation of mt-HK2 in situ which is prevented by IPC [18]. The fact that mt-HK2 from end-ische-
mic hearts can be further reduced in vitro indicates that the ischemic insult was not extreme,
suggesting that further damage could have been attained to the heart. This agrees with our previ-
ous findings [13] where variations to the standard perfusion protocol led to different amounts of
mt-HK2 being retained at end of ischemia, correlating with cardiac damage at reperfusion.
Fig 1. Effects of ischemia and low pH plus G6P treatments on mitochondrial-bound HK2. Incubation of mitochondria during isolation with factors know to
induce HK2 dissociation [18] completely removes HK2 from mitochondria: a—HK2 protein content (representative blots are shown on panel c and uncropped
membranes on S2b Fig), b—Total HK activity. Data are presented as mean ± SEM of 6–8 independent experiments on different mitochondrial preparations.
Differences between groups were evaluated by a matched pair (± G6P low pH) two-way ANOVA with interaction followed by Holm-Šı́dák pos-hoc test to correct
for multiple comparisons. pHK2 contentinteraction < 0:001; p
HK activity
interaction ¼ 0:011;
���, p< 0.001. Absolute values of citrate synthase (CS) activity (units per mg protein) were
2.30 ± 0.17, 2.59 ± 0.13, 2.69 ± 0.13 for pre-ischemia, end-ischemia and IPC end-ischemia, respectively. Corresponding values for low pH + G6P treated pre-
ischemia, end-ischemia and IPC end-ischemia mitochondria were 2.32 ± 0.17, 2.38 ± 0.12 and 2.66 ± 0.18 respectively. c—representative blots for HK2 and HK1,
as well as the ANT as loading control, of isolated mitochondrial fractions extracted from hearts perfused with different protocols (pre-ischemia, end-ischemia or
IPC end-ischemia) ± in vitro HK2 dissociation protocol (‘low pH plus G6P’); uncropped blots are shown on S2d Fig.
https://doi.org/10.1371/journal.pone.0234653.g001
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Further confirmation of the western blot data was provided by measurement of mitochon-
drial HK activity which was greatly reduced but not totally abolished by the protocol (Fig 1b).
The remaining activity can be accounted for by the bound HK1 that was not dissociated by the
treatment (Fig 1c), but which remains constant regardless of the perfusion protocol used as
previously shown in ex vivo perfusion [13, 23]. It should be noted that low pH alone had no
effect on total mt-HK activity (S2 Fig) or mt-HK2 content [18] in agreement with our previous
data obtained in permeabilized cardiac fibers.
In vitro dissociation of HK2 has no effect on mitochondrial respiration or
outer membrane permeabilization
Next, we investigated the effects of mt-HK2 removal on mitochondrial respiration and
OMMP as reflected by cytochrome c loss. Oxygen consumption was determined in the pres-
ence of both succinate that feeds electrons into Complex II and L-glutamate plus L-malate to
generate NADH which feeds electrons into Complex I. These conditions most closely match
the conditions in vivo [19]. Averaged traces (n = 8) of all analyzed groups are presented in
Fig 2a and show that there is no significant difference between normal mitochondria and
those depleted of HK2, regardless of the respiratory state (i.e. basal = state 2 and ADP-
stimulated = state 3). Nevertheless, mitochondria from end-ischemic hearts exhibited an
increase in state 2 respiration (31.7 ± 1.2 vs. 25.6 ± 1.6 nmol O2/min/mg of pre-ischemic,
p = 0.004, n = 8) and depressed state 3 respiration (Fig 2b) as reported previously [19]. As
expected, IPC treatment was able to prevent the latter, but state 2 rates remained slightly
higher than pre-ischemic values (34.65 ±1.4 nmol O2/min/mg, p = 0.056 vs. end-ischemia,
n = 8). In order to quantify OMMP we measured the stimulation of state 3 respiration induced
by addition of exogenous cytochrome c. Dissociation of HK2 alone had no effect on this
parameter (Fig 2c), but as we have previously reported [18], end-ischemia mitochondria
showed higher OMMP that was partially prevented by IPC treatment (Fig 2c). Overall our
data suggests that HK2 dissociation alone is insufficient to account for the reported deleterious
effects of ischemia on mitochondrial respiration and OMMP.
In vitro HK2 dissociation does not sensitize mitochondria to mPTP
opening
Another hallmark of ischemia-induced changes to mitochondria is an increased sensitivity to
mPTP opening. We investigated the effects of ischemia, IPC and mt-HK2 dissociation on the
sensitivity of mPTP opening to [Ca2+] under both de-energized and energized conditions. The
rate of A520 decrease induced by addition of Ca
2+ was used to determine the extent of mPTP
opening under de-energized conditions. Average traces (n = 5–6) in the absence and presence
of CsA are shown in Fig 3a and S3 Fig respectively, while mean rates of swelling (± SEM) are
reported in Fig 3b. Addition of a single bolus of Ca2+ to end-ischemia mitochondria caused a
fast and large decrease in A520 that was not observed in pre-ischemia mitochondria, confirm-
ing previous data [38] that ischemia enhances the sensitivity of the mPTP to [Ca2+] and that
IPC treatment was able to protect against this sensitization. As expected, incubation with CsA
inhibited the mPTP regardless of the perfusion protocol (Fig 3b), but differences between
groups were still observed. However, when HK2-depleted mitochondria were analyzed, no dif-
ferences were observed relative to their matched controls, with one exception. The rate of A520
change was slightly lower in HK2-depleted end-ischemia mitochondria compared to normal
end-ischemia mitochondria, although the response to CsA was similar in both groups.
The sensitivity of mPTP opening to [Ca2+] was also evaluated under energized conditions
using the calcium retention capacity assay. Average traces (n = 4–6) in the absence and
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presence of CsA are shown in Fig 4a and S4 Fig, respectively, while mean data (± SEM) for the
calcium loading capacity are reported in Fig 4b. As expected, end-ischemia mitochondria
accumulated less calcium compared to pre-ischemic mitochondria suggesting a higher sensi-
tivity to pore opening, and IPC treatment attenuated this effect. CsA also attenuated mPTP
opening but differences between groups were still present as was also observed under de-ener-
gized conditions. However, just as observed under de-energized conditions, the sensitivity of
HK2-depleted mitochondria to mPTP opening was similar to control-matched mitochondria,
regardless of the perfusion protocol or the presence of CsA. Taken together, these data imply
Fig 2. Effects of ischemia and low pH plus G6P treatments on mitochondrial respiration. Traces (a) are mean data of 8 independent experiments which are
analysed further in panels b-c where data are presented as means ± SEM. The shadow area on the top graph (a) represents the range used to calculate respiration
rates. (b) State 3 represents respiration in the presence of ADP. (c) Indirect assessment of OMMP by cytochrome c stimulation of mitochondrial respiration.
Differences between groups were evaluated by a matched pair (± G6P low pH) two-way ANOVA with interaction followed by Holm-Šı́dák pos-hoc test to correct
for multiple comparisons. �, p< 0.05; ���, p< 0.001.
https://doi.org/10.1371/journal.pone.0234653.g002
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Fig 3. Effects of ischemia and low pH plus G6P treatments on mPTP opening under de-energized conditions. (a) Mitochondrial swelling
associated with mPTP opening was triggered by addition of 83.5 μM free [Ca2+] and monitored by measurement of A520. Traces (a) are mean
data of 5–6 independent experiments which are analysed further in panels b-c where data are presented as means ± SEM. (b) The initial swelling
rate (d/dtmax A520) was calculated as the minimum of the first derivative of the absorbance traces and is shown as an absolute value. Cyclosporin
A (CsA—0.2 μM) was used to inhibit mPTP opening. Individual and averaged traces are presented in S3 Fig. Differences between groups were
evaluated by a matched pair (± G6P low pH) two-way ANOVA with interaction followed by Holm-Šı́dák pos-hoc test to correct for multiple
comparisons. Pwithout CsAinteraction ¼ 0:002. ���, p< 0.001. , p< 0.05 vs matched group without CsA.
https://doi.org/10.1371/journal.pone.0234653.g003
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Fig 4. Effects of ischemia and low pH plus G6P treatments on the sensitivity to mPTP opening under energized conditions. (a) mPTP opening
was evaluated by the calcium retention capacity assay with addition of 20 μM free [Ca2+] every 2 min. (b) Calcium-loading capacity was calculated as
the sum of the number of Ca2+ pulses until mPTP opening, defined by an incomplete plateau before the next Ca2+ addition. Traces (a) are mean data
of 4–6 independent experiments which are analysed further in panels b-c where data are presented as means ± SEM. CsA (0.2 μM) was used to inhibit
mPTP opening and, individual and averaged traces can be found in S4 Fig. Differences between groups were evaluated by a matched pair (± G6P low
pH) two-way ANOVA with interaction followed by Holm-Šı́dák pos-hoc test to correct for multiple comparisons. �, p< 0.05; ��, p< 0.01; ���,
p< 0.001. #, p< 0.05 vs matched group without CsA.
https://doi.org/10.1371/journal.pone.0234653.g004
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that the increased sensitivity to mPTP opening observed after ischemia, like the changes in
outer membrane permeability and respiration, must occur downstream of HK2 dissociation
from mitochondria. We postulated that this might involve proteins such as Drp1 that are
involved in mitochondrial fusion / fission and which we have previously proposed may pro-
vide a link between HK2 binding and modulation of mPTP activity [14].
Ischemia promotes Drp1 translocation to mitochondria in vivo but this is
not prevented by IPC
Drp1 translocation from cytosol to mitochondria is known to occur upon reperfusion [39] but
less is known about its localization during ischemia. In the light of the reported effects of Drp1
on the mPTP [40, 41] and the cardioprotection afforded by its inhibitor mdivi-1 [42], we
investigated Drp1 association with mitochondria at the end of ischemia. In Fig 5 we demon-
strate that the levels of the mitochondrial fission receptor (Mff), which is responsible for Drp1
recruitment, were significantly lower in end-ischemia mitochondria compared to the pre-
ischemic control (Fig 5, left). However, the amount of Drp1 present in end-ischemia
Fig 5. Effects of ischemia on the levels of mitochondrial fission proteins. The indicated proteins were collected either from total heart extracts or isolated
mitochondrial fractions and resolved by SDS-PAGE followed by immunoblotting (for uncropped blots see S5 Fig). Ischemic damage was assessed indirectly by
evaluating time to ischemic contracture [13]: 13.0 ± 0.8 min vs. 7.7 ± 1.2 min, p = 0.004, end-ischemia vs. IPC, respectively. Data in graphs are shown as
mean ± SEM of 6 independent experiments. Differences between groups were run separately for ‘total’ and ‘mitochondrial’ datasets and were evaluated by one-way
ANOVA followed by Dunnett’s post-hoc test to correct for multiple comparisons. �, p< 0.05; ��, p< 0.01.
https://doi.org/10.1371/journal.pone.0234653.g005
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mitochondria was higher than in their control counterparts (Fig 5, middle), suggesting that
Drp1 may be recruited to sites other than Mff. IPC prevented neither the increase in mito-
chondrial Drp1 nor the decrease in Mff associated with mitochondria at the end of ischemia.
These data imply that cardioprotection by IPC is independent of changes in Drp1 recruitment
but this may not rule out an effect of IPC on the mitochondrial fission machinery since it has
been shown recently that dynamin-2 (Dyn2) acts downstream of Drp1 recruitment in order to
complete fission of mitochondrial membranes [43]. Thus, we measured the amount of Dyn2
levels present in the mitochondria. In contrast to Drp1, the amount of mitochondria-associ-
ated Dyn2 at the end of ischemia was only slightly higher than pre-ischemic mitochondria (Fig
5, right; p = 0.060), but IPC significantly decreased mitochondria-associated Dyn2 (Fig 5,
right). This reduction reflects an effect of IPC on the recruitment Dyn2 to mitochondria since
cellular Dyn2 levels remained unchanged (Fig 5, right, ‘total’).
Overall, our data show that although Drp1 recruitment alone cannot explain the increased
sensitivity to mPTP observed after ischemia, it remains possible that it is the combination of
Drp1 and Dyn2 associated with mitochondria that can regulate the sensitivity of the mPTP
through changes in mitochondrial morphology [44]. In light of these observations, we investi-
gated the effects of ischemia on IMM morphology.
Effects of ischemia on inner mitochondrial morphology
Validating the use of light scattering to detect changes in mitochondrial morphology.
Previous work in this laboratory [27, 33] has shown that small changes in light-scattering (LS)
of isolated heart mitochondria can be induced by ligands of the adenine nucleotide translocase
(ANT) or sub-micromolar [Ca2+]. These LS changes are much smaller than those accompa-
nying mPTP opening and occur in the absence of significant alterations in total organelle vol-
ume. Although it remains unclear how the conformation of the ANT leads to changes in LS, it
is thought that it reflects changes in the inner mitochondrial morphology. The data of Fig 6
confirm this by using transmission electron microscopy (TEM) to evaluate mitochondrial
ultrastructure in parallel with LS measurements with the intention of using LS as a quantitative
measure of any small changes in the inner membrane morphology that may accompany ische-
mia and HK2 loss. In these experiments we used Ca2+ and two ligands of the ANT, ADP and
carboxyatractyloside (CAT), to modulate LS. ADP was chosen instead of bongkrekic acid
because the latter binds irreversibly to the ANT whereas the effects of ADP can be reversed by
CAT. Importantly, the effect of ADP is independent of ATP synthase activity since the buffer
is lacking phosphate (Pi) and is supplemented with oligomycin (a specific ATP synthase inhib-
itor). We also confirmed that the ANT content of mitochondria was unaffected by ischemia
and IPC (S6 Fig) and thus could not account for any changes in the effects of ANT ligands
seen between mitochondria following these treatments.
Fig 6a shows a typical trace of such a LS experiment for pre-ischemia mitochondria. As
expected, addition of a small amount of Ca2+ (1 μM free [Ca2+]), which is not sufficient to
induce mPTP opening, caused a decrease in LS that could be reversed by addition of 0.2 mM
ADP to induce the ‘m’ conformation of the ANT. The effect of ADP was itself rapidly reversed
by addition of 5 μM CAT (Fig 6a). In Fig 6b we use TEM to confirm that the Ca2+-induced
effects in LS are associated with changes in IMM morphology rather than total volume changes
(Fig 6c). This conclusion assumes that mitochondria maintain a spherical shape after isolation,
as reported by others [45]. We observed that IMM morphology could be broadly classified
into four distinct categories, illustrated in Fig 6b. Ca2+ addition induced a clear transition
from a classical conformation (Type I) towards rounded, nearly vesicular cristae without cris-
tae traversing, ie. Type III-IV (pType I< 0.001 and pType III< 0.001, vs. baseline; Fig 6B). In
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Fig 6. Effects of ANT ligands on the inner mitochondrial morphology in pre-ischemic mitochondria. a—monitoring of small fluctuations in light scattering in
the presence of ANT ligands in pre-ischemia control mitochondria. b—A sub-set of samples of the light scattering experiments shown in (a) were chemically fixed
and analyzed by TEM. Mitochondria were classified and counted accordingly to their inner membrane morphology by two independent operators blind to the
treatment. Type I, mitochondria present evenly spaced cristae with regular width, ie. classical conformation; Type II, mitochondria present irregular cristae width
but cristae are still thread-like, traversing from OMM to OMM. Spacing between cristae becomes irregular. Type III, mitochondria show a Type II configuration
but at least two vesicular-like cristae are present. It reflects a combination between Type II and Type IV configurations. Type IV, mitochondria present rounded,
nearly vesicular cristae without cristae traversing. Data in bars are presented as means of 2 independent experiments, each scored by two independent observers.
Total number of mitochondria employed (193–347) and other morphometric parameters can be found on S4 Table. c—frequency distributions of morphometric
data from TEM cross sections expressed relatively to the total number of analyzed mitochondria. Details about ‘OMM perimeter’ and ‘Total membrane perimeter’
can be found in Material and Methods and in the Supplemental Material. A Gaussian distribution was fitted to the data and independent fits between groups were
compared to a global fit sharing the same mean by the extra sum-of-squares F test and p values adjusted for multiple comparisons through Holm-Šı́dák pos-hoc
test. ���, p< 0.001. Abbreviations: Base.–baseline, CAT—after carboxyatractyloside treatment, end-isch.—end-ischemia, Per.—perimeter.
https://doi.org/10.1371/journal.pone.0234653.g006
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addition to investigate IMM structures further, morphometric analysis of EM cross sections of
the mitochondria was performed by determining the distribution of total membrane perimeter
(including IMM, calculated as described in Material and Methods and S7 Fig) normalized to
the OMM perimeter (Fig 6c, Ca2+ vs. baseline). These data show a shift towards higher values,
in agreement with an IMM rearrangement towards vesicular cristae.
When ADP was added after Ca2+ to reverse the decrease in LS, TEM micrographs con-
firmed that this was accompanied by restoration of evenly spaced cristae with regular width,
i.e. Type I (Fig 6b; pType I and pType III > 0.05, vs. baseline). Interestingly, morphometric analy-
sis showed that mitochondria presented a larger area in the presence of ADP (Fig 6c, left), but
assuming a spherical shape upon isolation, one should expect a decrease in LS as a conse-
quence of higher cross-section area. This is the opposite of what is observed (Fig 6a) and sug-
gests that morphological changes have a stronger effect on LS compared to total volume
changes, under these experimental conditions. Therefore, these observations indirectly con-
firm the robustness of our optical approach to monitor changes in inner membrane morphol-
ogy. The full recruitment of ANT to its ‘c’ conformation was achieved by addition of CAT.
This caused a rapid drop in LS (Fig 6a) which was associated with a change in the inner mem-
brane morphology towards Type III-IV (Fig 6b; pType I< 0.001 and pType III = 0.013, vs. base-
line). As might be expected, the total area and total membrane perimeter distributions more
closely resemble those in the presence of Ca2+, in agreement with the IMM classification.
Taken together these data confirm that under our experimental conditions, alterations in the
IMM morphology induced by ligand-induced changes in ANT conformation are detected as
small changes in LS as concluded previously [27, 33].
Effect of ischemia and HK2 dissociation on mitochondrial ultrastructure. In Fig 7 we
present TEM data on the effects of ischemia on IMM morphology. To our surprise, end-ische-
mia mitochondria were observationally no different from pre-ischemic mitochondria and
were mainly classified as Type I mitochondria (classical; Fig 7a). However, morphometric
analysis did reveal that end-ischemia mitochondria were slightly, but significantly larger than
pre-ischemic mitochondria (Fig 7b), consistent with a greater matrix volume as we have
reported previously [46].
To explore any subtle differences in mitochondrial morphology induced by ischemia and
IPC that might reflect changes in inner and outer membrane interactions or cristae structure
that are not readily visible by TEM, we investigated the response of IMM to [Ca2+] and ANT
ligands using the LS technique as described in Fig 6. This technique is also more readily quan-
tifiable and much less labor intensive than using TEM (Fig 8a). The amplitude and rate change
of LS induced by Ca2+ was considerably larger and faster in mitochondria from pre-ischemic
hearts than those from end-ischemia hearts (Fig 8b and 8e). However, IPC treatment failed to
re-establish the Ca2+-induced drop in LS to control values (Fig 8b). When ADP was added
after Ca2+, the amplitude and rate change in LS were consistently higher in mitochondria from
pre-ischemic hearts than those from end-ischemia hearts (Fig 8c and 8f). Interestingly,
although the LS plateau achieved after Ca2+ addition by end-ischemia and IPC end-ischemia
was similar (Fig 8a), IPC promoted a larger and faster ADP-induced change in LS compared
to end-ischemia group (Fig 8c and 8f). Similarly, the amplitude and rate of CAT-induced
change in LS were consistently lower in end-ischemia mitochondria compared to pre-ischemia
mitochondria (Fig 8d and 8g).
Next, we investigated the LS responses of mitochondria depleted of HK2 by prior treatment
with G-6-P at pH 6.3. The overall behavior of the HK-2 depleted mitochondria was similar to
their control counterparts with the following exceptions (Fig 8a, dashed lines). First, the ampli-
tude of the Ca2+-induced decrease in LS of HK2-depleted pre-ischemia mitochondria was
lower than for un-depleted controls, but still higher than end-ischemia mitochondria (Fig 8b).
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Second, the rate of ADP-induced LS change of HK2-depleted IPC end-ischemia mitochondria
was slower than for the same mitochondria without HK2-depletion, but still higher than end-
ischemia mitochondria (Fig 8f).
Overall, our data reveal that ischemia, which decreases mt-HK2 binding, decreased the LS
response to ANT ligands while IPC restored these effects. This implies that in parallel with its
depletion of mt-HK2, ischemia reduces the coupling between ANT conformation and IMM,
perhaps reflecting changes in inner and outer membrane interactions or cristae structure that
are not readily visible by TEM, and that this effect is prevented by IPC. However, just as with
the other parameters studied, modulating mt-HK2 alone had only a minor effect on this cou-
pling, suggesting that events other than mt-HK2 dissociation occur in situ to prime mitochon-
dria for mPTP opening on reperfusion.
Discussion
The role of mt-HK2 in cardioprotection has been extensively studied in this [13, 18, 19] and
other [20–23] laboratories. Pre-ischemic interventions, such as IPC, which prevent mt-HK2
dissociation afford substantial cardioprotection [13]. Indeed, we found a strong inverse corre-
lation between the amount of mt-HK2 remaining at end of ischemia and the infarct size upon
subsequent reperfusion. Although these studies have identified ischemia-induced events
upstream and downstream of HK2 displacement, it has not been established whether mt-HK2
dissociation is the primary signal mediating the ischemia-induced changes to mitochondria
that enhance mPTP opening on reperfusion. In the present investigation we have applied a
battery of biochemical techniques and ultrastructure imaging tools to assess whether mt-HK2
Fig 7. Inner mitochondrial classification of pre-ischemia vs. end-ischemia mitochondria (a) and the corresponding morphometric analysis of EM cross
sections (b). Data were processed as described in Fig 6 and are shown as mean ± SEM of 2 independent experiments. Total number of mitochondria employed
(193 for pre-ischemia and 412 for end-ischemia). �, p< 0.05; ���, p< 0.001.
https://doi.org/10.1371/journal.pone.0234653.g007
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Fig 8. Effects of ischemia and low pH plus G6P treatments on the inner mitochondrial morphology. (a) Inner mitochondrial
morphology was assessed indirectly by following small fluctuations in light scattering in the presence of ANT ligands. Traces (a) are
mean data of 8 independent experiments which are analysed further in panels b-g where data are presented as means ± SEM. (b-d) The
shadow area on the top graph represents the range used to calculate the amplitude of changes in A520. Amplitude values were
calculated as the absolute difference between the final averaged value after the previous addition (or baseline if the first) and the last
averaged value of the current addition. (e-g) Rates of change in A520 (d/dt A520) were calculated as the maximum (negative or positive)
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dissociation alone is sufficient to reproduce some or all of the changes in mitochondrial func-
tion observed following ischemia. Our rationale is that, if prevention of HK2 dissociation from
mitochondria is directly responsible for the attenuation of changes to mitochondria function
at the end of ischemia, then its removal from IPC end-ischemic mitochondria should change
these parameters back to those of non-preconditioned end-ischemic mitochondria. As in our
previous work with permeabilized fibres [18], we used the combination of high [G6P] with
low pH (6.3) to dissociate mt-HK2 in vitro during isolation of mitochondria which were then
returned to normal isolation buffer to ensure that all assays were performed under identical
conditions. This approach, which mimics ischemic conditions and is specific for HK isoform 2
(Fig 1), has advantages over peptide- or drug-based approaches, such as TAT-HK, AnP-HK or
clotrimazole, that can exert non-specific effects [17, 18, 47, 48]. For example, in the case of syn-
thetic peptides mimicking the HK2 binding peptide these might be carried through into the
assay and mimic the bound HK2 in its effects on the mPTP. Indeed, isolated cardiac mito-
chondria of mice overexpressing GFP fused to this peptide show successful dissociation of mt-
HK2 but retention of the recombinant protein [37].
It is important to note that our experimental design using isolated mitochondria allows us
to make important observations which would extremely difficult, if not impossible, to perform
using in intact cells / in vivo. First, our protocol dissociates HK2 from the mitochondria once
isolated thus ensuring the absence of cytoplasmic factors that might exert effects on mitochon-
drial function or morphology that are secondary to mt-HK2 release. Second, we isolate mito-
chondria either from baseline or after a damaging insult ± protective regimen, allowing us to
detect intramitochondrial differences that could account for increased sensitivity to pore open-
ing upon mt-HK2 release since changes would be maintained in our experimental setup. In
this context, we have previously shown [7, 19] that mitochondria isolated at end-
ischaemia ± IPC show similar [Ca2+]m accumulation while ischemic mitochondria show
increased ROS production, which are well established mPTP triggers. The fact that complete
removal of mt-HK2 does not change the sensitivity of the mPTP either in the baseline or the
other tested groups, which have mitochondria with modified behaviour, suggests that mt-HK2
was not acting as “the pin of a grenade”.
Loss of mt-HK2 binding is not the primary cause of OMM
permeabilization, cytochrome c loss and mPTP sensitization during
ischemia
If it were the dissociation of mt-HK2 from mitochondria during ischemia that were directly
responsible for cristae widening, OMMP, cytochrome c loss and mPTP sensitization during
ischemia, it would be anticipated that removal of mt-HK2 in vitro with high [G6P] and low pH
would mimic the effect of ischemia. However, in Fig 2 we demonstrate that mt-HK2 dissocia-
tion on its own is not sufficient to induce OMMP and cytochrome c release. This implies that
the entities responsible for OMMP are not pre-inserted in the mitochondria during ischemia
such that they could initiate their action upon HK2 release. Indeed the only member of the
Bcl2 family of proteins regulating OMMP that is changed in mitochondria following ischemia
is Bcl-XL whose expression decreases [19], but IPC did not prevent this loss despite preventing
of the first derivative of the absorbance traces. Differences between groups were evaluated by a matched pair (± G6P low pH) two-way
ANOVA with interaction followed by Holm-Šı́dák pos-hoc test to correct for multiple comparisons. �, p< 0.05; ��, p< 0.01; ���,
p< 0.001.
https://doi.org/10.1371/journal.pone.0234653.g008
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cytochrome c release [18]. Thus, we propose that the ability of IPC to maintain mitochondrial
morphology and OMM integrity during ischemia, and so facilitate cytochrome c retention, is
not a direct effect of preventing mt-HK2 dissociation.
Similarly, in vitro dissociation of mt-HK2 from mitochondria did not sensitize them to
mPTP opening (Fig 5) which is in stark contrast to the sensitization to mPTP opening seen in
mitochondria from ischemic hearts, where mtHK2 dissociation also occurs. The fact that
removal of mt-HK2 from IPC mitochondria does not increase mPTP activity to the level
observed in end-ischemia mitochondria provides evidence that the IPC-mediated inhibition
of mPTP opening is not caused directly by the bound HK2. This was somewhat unexpected in
the light of published data on the role of HK in apoptosis [16, 49] and mPTP modulation [17]
and implies that there is another regulatory factor involved in the sensitization of the mPTP by
ischemia that is attenuated by IPC. This is unlikely to involve either calcium or ROS since we
have shown that IPC modulates neither of these parameters in end-ischemic mitochondria [7]
which led us to focus our attention on Drp1, whose association with I/R injury has been stud-
ied previously [39].
Drp1 recruitment during ischemia alone cannot explain mitochondrial
sensitization to I/R injury
It has been reported that an increase in the intermembrane space occurs during mitochondrial
remodeling in apoptosis and that this is dependent on Dynamin-related protein 1 (Drp1) [50].
Drp1 is a cytosolic protein that translocates to mitochondria to initiate fission [43]. Further-
more, a similar redistribution of Drp1 to mitochondria has previously been reported to occur
upon reperfusion after ischemia [39]. These data are consistent with mitochondrial remodel-
ing playing an important role in determining the outcome of I/R damage. An attractive
hypothesis that we have discussed in more detail previously [14], is that mt-HK2 binding
might prevent the association of cytosolic factors, such as Drp1, with mitochondria during
ischemia and that it is these proteins that are the direct cause of the ischemic changes to mito-
chondria that activate the mPTP upon reperfusion. This would be consistent with the ability of
the pharmacological inhibitors of Drp1, mdivi-1 (GTPase activity) and the peptide inhibitor
P110 (Drp1-Fis1 interaction) to reduce infarct size in various models of cardiac I/R [42, 51],
even though side-effects [52] and target requirements [53] are disputed. However, although we
confirmed that ischemia did increase the recruitment of Drp1 to mitochondria, IPC failed to
prevent this despite affording substantial cardioprotection (Fig 5). Thus, Drp1 binding to
mitochondria alone cannot be responsible for ischemia-induced changes to mitochondria that
prime them for mPTP opening on reperfusion. However, it should be noted that Drp1 activity
and binding to mitochondria can be modulated by phosphorylation at various sites, as well as
by other post-translational modifications such as sumoylation and nitrosylation, although
there is considerable controversy over the effects, role and relevance of these modifications
[40, 54, 55]. Furthermore, only modifications that inhibit the fission activity of Drp1 without
causing its dissociation from mitochondria could account for our results and there is no clear
evidence for such a mechanism. In addition, previous data from this laboratory have provided
no evidence for a mitochondria-associated phosphorylated protein of the right size for Drp1
[11]. Another factor to consider is that Drp1 translocation is just one step in a cascade of
events that occur in order to constrict and allow polymeric ring-like structures to severe mito-
chondria [43]. The process starts with ER-mediated constriction of mitochondria at pre-Drp1
sites in an Mff- and MiD49/51-independent manner, followed by Drp1 recruitment by its
adaptor proteins and finishes with Dyn2 recruitment and assembly to complete fission [43].
Interestingly, ablation of Mfn2, a mitochondrial adaptor protein necessary for ER-
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mitochondria tethering, increases infarct size [56]. Indeed, modulation of any of these check-
points [51, 57, 58], or just inhibition of the last step, such as inhibition of Dyn2 by dynasore
[59], is sufficient to attenuate I/R injury. Our data from IPC treatment suggests that mt-HK2
cardioprotective mechanism could be due, in part, to prevention of mitochondrial recruitment
of Dyn2 rather than Drp1. However, the relationship between HK2 binding to mitochondria
and changes in Drp1/Dyn2 recruitment remains unclear. It is unlikely that mt-HK2 binding to
the OMM masks sites that bind Drp1 since, if this were the case IPC, which reduces mt-HK2
loss, should prevent the recruitment of Drp1 during ischemia which it did not. Nevertheless,
our data would be consistent with mt-HK2 attenuating the binding of Dyn2 that follows
recruitment of Drp1. We cannot rule out the possibility that the changes in mt-HK2 are sec-
ondary to changes in the recruitment of both Drp1 and Dyn2 and that mt-HK2 plays no role
in modulating mitochondrial morphology and mPTP sensitivity during ischemia. However,
our IMM morphometric analysis, discussed further below, suggests that contact sites between
the inner and outer membranes, which are disrupted in ischemia, may be involved in modulat-
ing mPTP sensitivity and hence in cardioprotection. Thus, dissociation of mt-HK2, which is
known to associate with contact sites, could co-operate with Drp1 and Dyn2 recruitment to
cause their destabilization in ischemia. IPC attenuates destabilization by preventing mt-HK2
dissociation.
Ischemic attenuation of mitochondrial morphology changes—Role of
contact sites
Modulation of IMM morphology by ANT ligands in our LS experiments (Fig 8) are thought to
be a surrogate marker of contact site lability [26]. Thus, we propose that the decreased magni-
tude and slow rate of ANT ligand-induced changes in LS exhibited by mitochondria from
ischemic hearts reflect lower contact site stability induced by ischemia and their maintenance
by IPC. Indeed, Bakker et. al [60], through the use of stereological methods, demonstrated that
the ability of heart mitochondria to form contact sites is lost during ischemia, worsening the
injury at reperfusion [60]. Our own data showing reduced rates of the creatine phosphate shut-
tle during reperfusion after prolonged ischemia and the prevention of this effect by IPC are
consistent with this proposal [13]. Furthermore, using permeabilized cardiomyocytes we were
able to show that mt-HK2 dissociation from mitochondria using G6P and low pH attenuated
creatine shuttle activity implying that stabilization of contact sites with mt-HK2 is important
for the efficient function of the shuttle [13]. However, removal of mt-HK2 had no significant
effect on the Ca2+ and ANT ligand-induced effects on LS of isolated mitochondria (Fig 8),
implying that these morphological changes are reflecting more than just contact site destabili-
zation. The TEM data of Fig 6 confirm this and show that LS changes are accompanied by
changes in the cristae structure and IMM morphology. IMM remodeling is required during
fission to ensure the proper segregation of IMM at both ends of the Drp1 constriction stalk
before a fission event. It is possible that the reduced LS responses seen in mitochondria at the
end of ischemia may indicate that, despite binding of Drp1 (Fig 5), the mitochondria have
undergone sub-optimal fission [61]. This process is known to lead to cytochrome c loss and so
IPC, by maintaining mitochondrial membrane contact sites may ensure IMM remodeling is
complete, thus preventing loss of cytochrome c.
Limitations of the current study and future avenues
Although the approach chosen to dissociate mt-HK2 in the current investigations can be con-
sidered physiological-like (low pH and high levels of G6P) it was performed ex vivo and out-
side the cellular context. While this gave us control over the dissociation process it does not
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allow exploration of any potential mechanistic link between mt-HK2 release and Dyn2 translo-
cation. However, the role and regulation of fusion / fission proteins in mPTP opening is com-
plex and controversial and to investigate this interaction more fully is beyond the scope of our
present study. We provide data that are suggestive of an involvement of Drp1 and Dnm2
which we hope may be a stimulus for further studies such as investigating the signaling path-
way(s) that modulate mt-HK2 binding and Dyn2 translocation to mitochondria during ische-
mia and IPC. It might also be illuminating to employ genetic models of altered HK/HK2
expression, but their utility is subject to significant limitations. First, overexpression of HK2
generally increases the cytosolic pool rather than promoting mitochondrial association of HK2
[62], consequently there is an increase in glycogen content [63], which is considered a cardio-
protective regimen. Second, knock-out could produce profound metabolic effects that might
mask the effects of acute mt-HK2 release on mitochondrial morphology / function. In this
regard, there is currently a need for the development of more efficient approaches to promote
acute mt-HK2 release as the available drug- and peptide-based procedures have significant
side-effects [15, 17, 18, 64].
Although we observed a concomitant association of Dyn2 with mitochondria when mt-
HK2 dissociates during ischemia, and that this effect is prevented by IPC, we cannot rule out
the possibility that the effect is independent of mt-HK2 release and represents a parallel effect
rather than a downstream event. Similarly, it would be of major importance to evaluate in
greater detail how Dyn2 and/or Drp1 modulate mitochondrial ultrastructure which was pres-
ently only assessed using light scattering.
Conclusion
We have shown that release of mitochondrial-bound HK2 in vivo during ischemia does not
affect end-ischemia mitochondrial function directly. Rather, we propose the effects are indirect
through destabilization of contact sites between mitochondrial inner and outer membranes.
These are thought to be the site of HK2 binding and are important for the efficient operation
of the creatine shuttle. IPC, by maintaining mt-HK2 binding, stabilizes these contact sites pre-
venting their disruption during ischemia. Ischemia also causes the recruitment of Drp1 and
Dyn2 to mitochondria that together mediate changes in mitochondrial morphology and cris-
tae structure to enhance cytochrome c release and sensitizes mPTP opening on reperfusion.
We propose that mt-HK2 binding to contact sites may prevent Drp1-mediated recruitment of
Dyn2 thus explaining how IPC exerts its cardioprotective effects.
Supporting information
S1 Fig. Diagram depicting the experimental design and protocol for mitochondrial prepa-
ration and treatment. Note that the dissociation protocol used to release mitochondrial-
bound HK2 occurs prior to data acquisition and that dissociation agents are absent from the
washing buffers.
(TIFF)
S2 Fig. Effect of washing buffer pH on mt-HK2 dissociation assessed through the activity
of the remaining mt-HK. Total HK activity of mitochondria pre-treated with dissociation
buffer during isolation protocol (a); data are presented as mean ± SEM of 4 independent
experiments on different mitochondrial preparations. Differences between groups were evalu-
ated by a matched pair (± low pH) t Student’s test. (b) uncropped and representative immuno-
blot against HK2 on isolated mitochondrial fractions. (c) Coomassie staining of membrane
shown in (b). The loading control for membrane in (b) is shown on S6b Fig (the mitochondrial
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protein ANT). (d) uncropped immunoblots against HK2, HK1 and ANT as shown on main
Fig 1.
(TIFF)
S3 Fig. Protective effects of 0.2 μM cyclosporine A (CsA) on the sensitivity of mPTP open-
ing under de-energized conditions. Mitochondrial swelling associated with mPTP opening
was triggered by addition of 83.5 μM free Ca2+ and monitored by measurement of A520 (a).
Data are presented either as mean of 5–6 independent experiments (bi-ci) or overlaid with
individual runs (bii-cii) for the perfusion groups in the study (pre-ischaemia—bi, bii; end-
ischaemia—ci, cii; and, IPC end-ischaemia—di, dii).
(TIFF)
S4 Fig. Protective effects of 0.2 μM CsA on the sensitivity of mPTP opening under ener-
gized conditions. mPTP opening was evaluated by the calcium retention capacity assay with
addition of 20 μM free Ca2+ every 2 min (a). Data are presented as mean independent experi-
ments (bi-ci) or overlaid with individual runs (bii-cii) for the perfusion groups in the study
(pre-ischaemia—bi, bii; end-ischaemia—ci, cii; and, IPC end-ischaemia—di, dii).
(TIFF)
S5 Fig. Representative western blots for Fig 5. Dyn-2 (a, b), Drp1 (a, b) and Mff (c) data
shown on Fig 5. Total extracts are shown in (a) while mitochondrial fractions are shown in
(b), for Dyn-2 and Drp1. For Mff only mitochondrial fractions were analyzed. GAPDH was
used as loading control for the total extracts while VDAC was used for mitochondrial fractions
instead. The vertical white bar along the blots on (a) and (b) indicate that although the samples
were in the same membrane they were not next to each other (non-relevant samples are omit-
ted in the picture).
(TIFF)
S6 Fig. Effect of ischemia and “low pH + G6P” on the levels of mitochondrial ANT protein.
Data are presented as mean ± SEM of 6–8 independent mitochondrial fraction samples (a).
For details on the use of “low pH + G6P” please see the Material and methods section. Differ-
ences between groups were evaluated by a matched pair (± G6P low pH) two-way ANOVA
with interaction followed by Holm-Šı́dák pos-hoc test to correct for multiple comparisons. (b)
representative western blot of the analysis in (a). (c) loading control of the western blot shown
on (b) by Coomassie staining.
(TIFF)
S7 Fig. EM segmentation pipeline. Example of the image-processing pipeline for mitochon-
drial membranes segmentation in EM micrographs. A—original; B—band pass filter; C—Otsu
threshold; D—particle size filtering.
(TIF)
S1 Table. Hemodynamic data monitored before ischemia of hearts used for mitochondrial
isolation. Hearts were perfused according to the protocols described in the Material and
Methods section. All the data presented in the table correspond to hemodynamic function
recorded prior to the index ischemia at the end of the stabilization period. Data for each
parameter were analyzed by a one-way ANOVA followed by Holm-Šı́dák pos-hoc test to cor-
rect for multiple comparisons. �, p<0.05 vs pre-ischemia or ischemia. Abbreviations: EDP—
end-diastolic pressure; IPC—ischemic preconditioning; Isch.—ischemia; RRP; rate pressure
product; SP—systolic pressure.
(DOCX)
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S2 Table. Parameters relating to ischemic contracture of hearts used for mitochondrial iso-
lation. All the data presented in the table were obtained during the index ischemia. T0 indi-
cates time at which rigor started; Amax, rigor maximum amplitude. Data for each parameter
was analyzed by a two-tail Student’s t test. �, p<0.05. Abbreviations: IPC—ischemic precondi-
tioning; n.a.—not applicable.
(DOCX)
S3 Table. Hemodynamic data monitored during reperfusion for the group of hearts used
to study infarct size. Hearts were perfused according to the protocols described in the Mate-
rial and Methods section. All the data presented in the table correspond to hemodynamic
function recorded after 5 and 60 min of reperfusion. Infarct size was assessed by the TTC
staining 120min after starting reperfusion. Data for each parameter were analyzed by a two-
tail Student’s t test. �, p< 0.05; ���, p< 0.001. Abbreviations: AAR—area at risk; IPC—ische-
mic preconditioning.
(DOCX)
S4 Table. Morphometric data from EM micrographs of isolated mitochondria incubated
with different ANT ligands. Data are presented as mean ± SD and differences relatively to
baseline were analyzed by a one-way ANOVA followed by Dunnet’s pos-hoc test to correct for
multiple comparisons. ���, p<0.001 vs baseline.
(DOCX)
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